These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31455247)

  • 1. Choosing the most appropriate existing type 2 diabetes risk assessment tool for use in the Philippines: a case-control study with an urban Filipino population.
    Agarwal G; Guingona MM; Gaber J; Angeles R; Rao S; Cristobal F
    BMC Public Health; 2019 Aug; 19(1):1169. PubMed ID: 31455247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study.
    Mavrogianni C; Lambrinou CP; Androutsos O; Lindström J; Kivelä J; Cardon G; Huys N; Tsochev K; Iotova V; Chakarova N; Rurik I; Moreno LA; Liatis S; Makrilakis K; Manios Y;
    Diabetes Res Clin Pract; 2019 Apr; 150():99-110. PubMed ID: 30796939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the CANRISK tool in the identification of dysglycemia in a Canadian South Asian Population.
    Agarwal G; Jiang Y; Lemieux C; Rogers Van Katwyk S; Mao Y; Orpana H; Fong M; Morrison H
    Health Promot Chronic Dis Prev Can; 2018; 38(7-8):287-294. PubMed ID: 30129716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of the Finnish Diabetes Risk Score, a modified Finnish Diabetes Risk Score and a simplified Finnish Diabetes Risk Score in community-based cross-sectional screening of undiagnosed type 2 diabetes in the Philippines.
    Ku GM; Kegels G
    Prim Care Diabetes; 2013 Dec; 7(4):249-59. PubMed ID: 23953706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population.
    Robinson CA; Agarwal G; Nerenberg K
    Chronic Dis Inj Can; 2011 Dec; 32(1):19-31. PubMed ID: 22153173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population.
    Rokhman MR; Arifin B; Zulkarnain Z; Satibi S; Perwitasari DA; Boersma C; Postma MJ; van der Schans J
    PLoS One; 2022; 17(7):e0269853. PubMed ID: 35862370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the CANRISK tool in the identification of dysglycemia in First Nations and Métis in Canada.
    Agarwal G; Jiang Y; Rogers Van Katwyk S; Lemieux C; Orpana H; Mao Y; Hanley B; Davis K; Leuschen L; Morrison H
    Health Promot Chronic Dis Prev Can; 2018 Feb; 38(2):55-63. PubMed ID: 29443485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a Finnish Diabetes Risk Score in detecting undiagnosed diabetes among Kenyans aged 18-69 years.
    Mugume IB; Wafula ST; Kadengye DT; Van Olmen J
    PLoS One; 2023; 18(4):e0276858. PubMed ID: 37186010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation and validation of diabetes risk score for urban Asian Indians.
    Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
    Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.
    Lotfaliany M; Hadaegh F; Asgari S; Mansournia MA; Azizi F; Oldenburg B; Khalili D
    Arch Iran Med; 2019 Mar; 22(3):116-124. PubMed ID: 31029067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol.
    Salinero-Fort MÁ; de Burgos-Lunar C; Mostaza Prieto J; Lahoz Rallo C; Abánades-Herranz JC; Gómez-Campelo P; Laguna Cuesta F; Estirado De Cabo E; García Iglesias F; González Alegre T; Fernández Puntero B; Montesano Sánchez L; Vicent López D; Cornejo Del Río V; Fernández García PJ; Sabín Rodríguez C; López López S; Patrón Barandío P;
    BMJ Open; 2015 Jul; 5(7):e007195. PubMed ID: 26220868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.
    Jølle A; Midthjell K; Holmen J; Carlsen SM; Tuomilehto J; Bjørngaard JH; Åsvold BO
    BMJ Open Diabetes Res Care; 2019; 7(1):e000769. PubMed ID: 31803483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Finnish Diabetes Risk Score (FINDRISC) and Modified Asian FINDRISC (ModAsian FINDRISC) for screening of undiagnosed type 2 diabetes mellitus and dysglycaemia in primary care.
    Lim HM; Chia YC; Koay ZL
    Prim Care Diabetes; 2020 Oct; 14(5):494-500. PubMed ID: 32156516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of dysglycemia risk in the Kitikmeot region of Nunavut: using the CANRISK tool.
    Jiang Y; Rogers Van Katwyk S; Mao Y; Orpana H; Argwal G; de Groh M; Skinner M; Clarke R; Morrison H
    Health Promot Chronic Dis Prev Can; 2017 Apr; 37(4):114-122. PubMed ID: 28402800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of risk of diabetes by using Indian Diabetic risk score (IDRS) in Indian population.
    Nagarathna R; Tyagi R; Battu P; Singh A; Anand A; Nagendra HR
    Diabetes Res Clin Pract; 2020 Apr; 162():108088. PubMed ID: 32087269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
    Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
    Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.